These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9917572)

  • 21. A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.
    Ahmed A; Centor RM; Weaver MT; Perry GJ
    Am Heart J; 2005 Apr; 149(4):737-43. PubMed ID: 15990761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACE inhibitors after acute myocardial infarction.
    Cheng TO
    Arch Intern Med; 1995 Mar; 155(6):645. PubMed ID: 7887763
    [No Abstract]   [Full Text] [Related]  

  • 23. Valsartan an alternative to ACE inhibitor in high-risk MI.
    Geriatrics; 2004 Jan; 59(1):45. PubMed ID: 14755870
    [No Abstract]   [Full Text] [Related]  

  • 24. What does ATLAS really tell us about "high" dose angiotensin-converting enzyme inhibition in heart failure?
    Nicklas JM; Cohn JN; Pitt B
    J Card Fail; 2000 Jun; 6(2):165-8. PubMed ID: 10908091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-versus low-dose ACE inhibitor therapy in chronic heart failure.
    Roffman DS
    Ann Pharmacother; 2004 May; 38(5):831-8. PubMed ID: 15026561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ELITE II. AT1-blockers not better, but more tolerable than ACE-inhibitors].
    Berger D
    Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712087
    [No Abstract]   [Full Text] [Related]  

  • 27. What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?
    Dickstein K
    Am Heart J; 2003 May; 145(5):754-7. PubMed ID: 12766730
    [No Abstract]   [Full Text] [Related]  

  • 28. A hard look at angiotensin receptor blockers in heart failure.
    Gring CN; Francis GS
    J Am Coll Cardiol; 2004 Nov; 44(9):1841-6. PubMed ID: 15519017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment after myocardial infarct with ACE inhibitors. Are all problems solved by "mega-studies"?].
    Ertl G; Kochsiek K
    Internist (Berl); 1995 Jan; 36(1):62-6. PubMed ID: 7883533
    [No Abstract]   [Full Text] [Related]  

  • 30. Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database.
    Avanzini F; Ferrario G; Santoro L; Peci P; Giani P; Santoro E; Franzosi MG; Tognoni G;
    Am Heart J; 2002 Dec; 144(6):1018-25. PubMed ID: 12486426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining aspirin with angiotensin converting enzyme inhibitors in heart failure: how safe is it?
    Mehta H; Mahajan A; Bansal N; Vaidya S; Pathak L
    J Assoc Physicians India; 1998 Nov; 46(11):953-6. PubMed ID: 11229224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
    Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
    Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Underuse of evidence-based therapies.
    Hlatky MA
    Circulation; 2004 Aug; 110(6):644-5. PubMed ID: 15302805
    [No Abstract]   [Full Text] [Related]  

  • 34. Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?
    van de Wal RM; van Veldhuisen DJ; van Gilst WH; Voors AA
    Eur Heart J; 2005 Nov; 26(22):2361-7. PubMed ID: 16105846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Have angiotensin receptor blockers lived up to expectations?
    Fitchett D
    Can J Cardiol; 2005 May; 21(7):569-75. PubMed ID: 15940354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
    Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
    Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments pro].
    de Teresa E
    Rev Esp Cardiol; 1994 Nov; 47(11):723-8. PubMed ID: 7800901
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments contra].
    Rodríguez Lambert JL; Moris C
    Rev Esp Cardiol; 1994 Nov; 47(11):719-22. PubMed ID: 7800900
    [No Abstract]   [Full Text] [Related]  

  • 39. [Large-scale clinical trials of patients with congestive heart failure].
    Sasayama S
    Nihon Naika Gakkai Zasshi; 1997 Dec; 86(12):2314-9. PubMed ID: 9465655
    [No Abstract]   [Full Text] [Related]  

  • 40. [Economical treatment of heart failure].
    Sonntag F
    Med Klin (Munich); 1996 Feb; 91(2):111. PubMed ID: 8850107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.